The CRISPR/Cas system is a powerful tool employed by scientists to edit disease-causing genes in vitro. The individual components of this system are composed of structural elements that pose a challenge for delivery to target cells. To overcome this barrier to entry, scientists have designed various viral and nonviral methods to improve the efficiency of CRISPR/Cas delivery.
Download this infographic from Drug Discovery News to learn about the various viral and nonviral methods that scientists use to efficiently deliver CRISPR/Cas to target cells.
Drug Discovery News
1000 N West Street | Wilmington | Delaware | 19801 | US
Email: privacy@drugdiscoverynews.com
© 2021 Old River Publications LLC. All rights reserved
Drug Discovery News needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy